Vir Biotechnology and Alnylam Join the Fight Against COVID-19

Yet another biotech has joined the fray against the novel coronavirus: Alnylam Pharmaceuticals ( NASDAQ:ALNY ) and Vir Biotechnology ( NASDAQ:VIR ) on Wednesday announced they were expanding their ongoing collaboration to include an attempt to develop RNA interference (RNAi) treatments for SARS-CoV-2. According to the American Society for […]

Click here to view original web page at